• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉病毒 VP35 与泛素链非共价相互作用,促进病毒复制。

Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication.

机构信息

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.

Molecular Biology and Virology Laboratory, Faculty of Medicine and Health Sciences, Corporación Universitaria Empresarial Alexander von Humboldt, Armenia, Colombia.

出版信息

PLoS Biol. 2024 Feb 29;22(2):e3002544. doi: 10.1371/journal.pbio.3002544. eCollection 2024 Feb.

DOI:10.1371/journal.pbio.3002544
PMID:38422166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10942258/
Abstract

Ebolavirus (EBOV) belongs to a family of highly pathogenic viruses that cause severe hemorrhagic fever in humans. EBOV replication requires the activity of the viral polymerase complex, which includes the cofactor and Interferon antagonist VP35. We previously showed that the covalent ubiquitination of VP35 promotes virus replication by regulating interactions with the polymerase complex. In addition, VP35 can also interact non-covalently with ubiquitin (Ub); however, the function of this interaction is unknown. Here, we report that VP35 interacts with free (unanchored) K63-linked polyUb chains. Ectopic expression of Isopeptidase T (USP5), which is known to degrade unanchored polyUb chains, reduced VP35 association with Ub and correlated with diminished polymerase activity in a minigenome assay. Using computational methods, we modeled the VP35-Ub non-covalent interacting complex, identified the VP35-Ub interacting surface, and tested mutations to validate the interface. Docking simulations identified chemical compounds that can block VP35-Ub interactions leading to reduced viral polymerase activity. Treatment with the compounds reduced replication of infectious EBOV in cells and in vivo in a mouse model. In conclusion, we identified a novel role of unanchored polyUb in regulating Ebola virus polymerase function and discovered compounds that have promising anti-Ebola virus activity.

摘要

埃博拉病毒(EBOV)属于高度致病病毒家族,可导致人类严重出血热。EBOV 的复制需要病毒聚合酶复合物的活性,该复合物包括辅助因子和干扰素拮抗剂 VP35。我们之前的研究表明,VP35 的共价泛素化通过调节与聚合酶复合物的相互作用来促进病毒复制。此外,VP35 还可以与泛素(Ub)非共价相互作用;然而,这种相互作用的功能尚不清楚。在这里,我们报告 VP35 与游离(无锚)K63 连接的多 Ub 链相互作用。异位表达已知可降解无锚多 Ub 链的肽酶 T(USP5),可减少 VP35 与 Ub 的结合,并与微基因组测定中的聚合酶活性降低相关。我们使用计算方法构建了 VP35-Ub 非共价相互作用的模型,鉴定了 VP35-Ub 相互作用的表面,并测试了突变以验证该界面。对接模拟确定了可阻断 VP35-Ub 相互作用从而降低病毒聚合酶活性的化学化合物。这些化合物的处理降低了细胞内和体内感染性 EBOV 的复制,在小鼠模型中也有很好的效果。总之,我们发现了无锚多 Ub 在调节埃博拉病毒聚合酶功能中的新作用,并发现了具有潜在抗埃博拉病毒活性的化合物。

相似文献

1
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication.埃博拉病毒 VP35 与泛素链非共价相互作用,促进病毒复制。
PLoS Biol. 2024 Feb 29;22(2):e3002544. doi: 10.1371/journal.pbio.3002544. eCollection 2024 Feb.
2
Ebola Virus VP35 Interacts Non-Covalently with Ubiquitin Chains to Promote Viral Replication Creating New Therapeutic Opportunities.埃博拉病毒VP35与泛素链非共价相互作用以促进病毒复制,从而创造新的治疗机会。
bioRxiv. 2023 Jul 15:2023.07.14.549057. doi: 10.1101/2023.07.14.549057.
3
The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.宿主E3泛素连接酶TRIM6使埃博拉病毒VP35蛋白泛素化并促进病毒复制。
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00833-17. Print 2017 Sep 15.
4
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.洋蓟素通过对抗VP35对β干扰素产生的抑制作用来阻断埃博拉病毒复制。
Antiviral Res. 2022 Feb;198:105251. doi: 10.1016/j.antiviral.2022.105251. Epub 2022 Jan 20.
5
Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.埃博拉病毒包含体的形成和 RNA 合成受核蛋白与 VP35 相互作用的新结构域控制。
J Virol. 2020 Jul 30;94(16). doi: 10.1128/JVI.02100-19.
6
Ebola virus replication is regulated by the phosphorylation of viral protein VP35.埃博拉病毒的复制受病毒蛋白 VP35 磷酸化的调节。
Biochem Biophys Res Commun. 2020 Jan 15;521(3):687-692. doi: 10.1016/j.bbrc.2019.10.147. Epub 2019 Nov 4.
7
Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.泛素化埃博拉病毒 VP35 在赖氨酸 309 处调节病毒转录和组装。
PLoS Pathog. 2022 May 9;18(5):e1010532. doi: 10.1371/journal.ppat.1010532. eCollection 2022 May.
8
Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain.埃博拉病毒 VP35 IFN 抑制结构域疏水区功能的重要性。
Viruses. 2021 Nov 20;13(11):2316. doi: 10.3390/v13112316.
9
Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.埃博拉病毒 VP35 扰乱 I 型干扰素信号转导以促进病毒复制。
Virol Sin. 2023 Dec;38(6):922-930. doi: 10.1016/j.virs.2023.10.004. Epub 2023 Oct 13.
10
Evasion of interferon responses by Ebola and Marburg viruses.埃博拉和马尔堡病毒对干扰素反应的逃避。
J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076.

引用本文的文献

1
NRGSuite-Qt: a PyMOL plugin for high-throughput virtual screening, molecular docking, normal-mode analysis, the study of molecular interactions, and the detection of binding-site similarities.NRGSuite-Qt:一款用于高通量虚拟筛选、分子对接、正常模式分析、分子相互作用研究以及结合位点相似性检测的PyMOL插件。
Bioinform Adv. 2025 Jun 16;5(1):vbaf129. doi: 10.1093/bioadv/vbaf129. eCollection 2025.
2
The Dual Role of TRIM7 in Viral Infections.TRIM7 在病毒感染中的双重作用。
Viruses. 2024 Aug 12;16(8):1285. doi: 10.3390/v16081285.
3
Unconventional posttranslational modification in innate immunity.

本文引用的文献

1
Surfaces: a software to quantify and visualize interactions within and between proteins and ligands.表面:一种用于量化和可视化蛋白质和配体内部及之间相互作用的软件。
Bioinformatics. 2023 Oct 3;39(10). doi: 10.1093/bioinformatics/btad608.
2
Unanchored ubiquitin chain sustains RIG-I-induced interferon-I activation and controls selective gene expression.非锚定泛素链维持RIG-I诱导的I型干扰素激活并控制选择性基因表达。
Sci Bull (Beijing). 2021 Apr 30;66(8):794-802. doi: 10.1016/j.scib.2020.11.003. Epub 2020 Nov 9.
3
RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning.
先天免疫中的非传统翻译后修饰。
Cell Mol Life Sci. 2024 Jul 6;81(1):290. doi: 10.1007/s00018-024-05319-8.
4
Surfaces: a software to quantify and visualize interactions within and between proteins and ligands.表面:一种用于量化和可视化蛋白质和配体内部及之间相互作用的软件。
Bioinformatics. 2023 Oct 3;39(10). doi: 10.1093/bioinformatics/btad608.
RCSB 蛋白质数据库(RCSB.org):提供实验测定的 PDB 结构以及来自人工智能/机器学习的 100 万个蛋白质计算结构模型。
Nucleic Acids Res. 2023 Jan 6;51(D1):D488-D508. doi: 10.1093/nar/gkac1077.
4
Ebola treatment: progressing with pragmatism.埃博拉治疗:务实推进
Lancet Microbe. 2022 Oct;3(10):e723. doi: 10.1016/S2666-5247(22)00264-6.
5
Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.泛素化埃博拉病毒 VP35 在赖氨酸 309 处调节病毒转录和组装。
PLoS Pathog. 2022 May 9;18(5):e1010532. doi: 10.1371/journal.ppat.1010532. eCollection 2022 May.
6
TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction.TRIM25 和 ZAP 靶向埃博拉病毒核糖核蛋白复合物以介导干扰素诱导的限制。
PLoS Pathog. 2022 May 9;18(5):e1010530. doi: 10.1371/journal.ppat.1010530. eCollection 2022 May.
7
Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways.阻断 HDAC6-泛素相互作用可损害流感和寨卡病毒感染及细胞应激途径。
Cell Rep. 2022 Apr 26;39(4):110736. doi: 10.1016/j.celrep.2022.110736.
8
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association.埃博拉病毒 VP35 通过与 AKIP1 结合劫持 PKA-CREB1 通路从而实现复制和发病机制。
Nat Commun. 2022 Apr 26;13(1):2256. doi: 10.1038/s41467-022-29948-4.
9
The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity.RNA 解旋酶 DHX16 识别特定的病毒 RNA,从而触发 RIG-I 依赖性先天抗病毒免疫。
Cell Rep. 2022 Mar 8;38(10):110434. doi: 10.1016/j.celrep.2022.110434.
10
Structural and Functional Aspects of Ebola Virus Proteins.埃博拉病毒蛋白的结构与功能方面
Pathogens. 2021 Oct 15;10(10):1330. doi: 10.3390/pathogens10101330.